Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/21638
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYannitsi, S. G.en
dc.contributor.authorManoussakis, M. N.en
dc.contributor.authorMavridis, A. K.en
dc.contributor.authorTzioufas, A. G.en
dc.contributor.authorLoukas, S. B.en
dc.contributor.authorPlataris, G. K.en
dc.contributor.authorLiakos, A. D.en
dc.contributor.authorMoutsopoulos, H. M.en
dc.date.accessioned2015-11-24T19:16:17Z-
dc.date.available2015-11-24T19:16:17Z-
dc.identifier.issn0006-3223-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/21638-
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAffective Disorders, Psychotic/immunologyen
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectAlcoholism/immunologyen
dc.subjectAntibodies, Antinuclear/analysisen
dc.subjectAutoantibodies/*analysisen
dc.subjectBorderline Personality Disorder/immunologyen
dc.subjectChronic Diseaseen
dc.subjectDNA/immunologyen
dc.subjectDelirium, Dementia, Amnestic, Cognitive Disorders/immunologyen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectIntellectual Disability/immunologyen
dc.subjectMaleen
dc.subjectMental Disorders/*immunologyen
dc.subjectMiddle Ageden
dc.subjectPsychotic Disorders/psychologyen
dc.subjectSchizophrenia/immunologyen
dc.titleFactors related to the presence of autoantibodies in patients with chronic mental disordersen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/2328270-
heal.identifier.secondaryhttp://ac.els-cdn.com/000632239090590X/1-s2.0-000632239090590X-main.pdf?_tid=30df17e031de19a87fd7e38e57df2f75&acdnat=1337244488_36e3389629f6b79b39bb3883b6ad343a-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1990-
heal.abstractSerum samples from 307 patients with various chronic mental disorders were examined for the presence of several autoantibodies. Autoantibodies detected included antinuclear antibodies (ANA) in 122/307 (39.7%), rheumatoid factor (RF) in 23/307 (7.5%), anticardiolipin antibodies (anti-CL) in 23/304 (7.6%, IgM in 12 patients, IgG in 13 patients). Isolated cases with IgG anti-dsDNA, anti-Ro(SSA), and anti-Ro(SSA)/anti-La(SSB) were also identified. The analysis of data revealed that the aging process in patients studied contributed significantly to the incidence of ANA (p less than 0.0001) and RF (p less than 0.01). In addition, the chronic administration of chlorpromazine (CPZ) was associated with the presence of ANA (p less than 0.03) as well as with the presence of IgM and/or IgG anti-CL antibodies (p less than 0.003). Finally, the diagnosis of schizophrenia correlated with the presence of ANA (p less than 0.001). This study represents the autoantibody profile of patients with chronic mental disorders and emphasizes the multifactorial origin of autoantibody response in psychiatric patients.en
heal.journalNameBiol Psychiatryen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Yannitsi-1990-Factors related to t.pdf1 MBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons